Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-03-25
1996-04-23
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435212, 435215, 435216, 435226, 424 9463, 424 9464, A61K 3800, A61K 3848
Patent
active
055103308
ABSTRACT:
The invention involves thromboembolically effective compositions and therapeutic methods. Thrombolytically active proteins are combined with anticoagulants, as long as the anticoagulant is not heparin. The anticoagulant is administered in an intravenous bolus form, while the thrombolytically active protein may be administered via intravenous bolus, or intravenous infusion.
REFERENCES:
patent: 4970159 (1990-11-01), Dodd
patent: 4980165 (1990-12-01), Isaacs et al.
patent: 5049132 (1991-09-01), Shaffer
patent: 5084274 (1992-01-01), Griffin et al.
patent: 5126134 (1992-06-01), Heim et al.
patent: 5189019 (1993-02-01), Paladino et al.
patent: 5196404 (1993-03-01), Maraganore et al.
patent: 5204323 (1993-04-01), Findlay et al.
patent: 5223256 (1993-06-01), Stern et al.
patent: 5240913 (1993-08-01), Maraganore et al.
patent: 5242688 (1993-09-01), Burck et al.
patent: 5242810 (1993-09-01), Maraganore et al.
patent: 5350578 (1994-09-01), Griffin et al.
Fischer Stephan
Martin Ulrich
Boehringer Mannheim GmbH
Lilling Herbert J.
LandOfFree
Combinations of thrombolytically active proteins and non-heparin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of thrombolytically active proteins and non-heparin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of thrombolytically active proteins and non-heparin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2308514